Skip to content

Age Related Macular Degeneration 11 C2677774

Published: July 22, 2026Updated: August 20, 2026

An eye condition affecting older adults that damages central vision. Treatment depends on type and may include injections, laser therapy, or supplements.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Central vision loss

!

Sudden central scotoma

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Blurry central vision

(ophthalmologic)

Difficulty reading or recognizing faces

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anti-VEGF intravitreal injections

Vascular endothelial growth factor inhibitors are administered via injection into the eye to reduce abnormal blood vessel growth and leakage associated with wet AMD. Regular monitoring and repeated treatments are typically required.

medication
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

AREDS2 supplementation

Age-Related Eye Disease Study 2 formula supplements containing vitamins C, E, zinc, copper, lutein, and zeaxanthin to slow disease progression. These nutrients support macular health and may reduce risk of advancement.

dietary

Additional treatment options

Photodynamic laser therapy

A light-activated drug is injected intravenously and activated by a cold laser to seal leaking blood vessels while minimizing damage to surrounding retinal tissue. Less commonly used than anti-VEGF therapy.

procedure

Smoking cessation program

Structured smoking cessation intervention including counseling and nicotine replacement options to eliminate this major modifiable AMD risk factor. Cessation benefits eye health at any age.

lifestyle

Regular ophthalmologic surveillance

Scheduled comprehensive eye exams with retinal imaging and Amsler grid self-monitoring at home to detect disease progression or new blood vessel formation early. Frequency adjusted based on disease severity.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Age Related Macular Degeneration 11 C2677774?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mitchell P, Chakravarthy U, Gale R, Schmidt-Erfurth U. Guidelines for the management of neovascular age-related macular degeneration. Prog Retin Eye Res. 2023.

guideline2023
2

Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration: a review. Lancet. 2022.

review2022
3

Spooner K, Hong T, Wijeyakumar W, Chang A. Comparative effectiveness of anti-VEGF agents for neovascular age-related macular degeneration: meta-analysis. JAMA Ophthalmol. 2021.

meta_analysis2021
4

Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration: randomized controlled trial. N Engl J Med. 2020.

clinical_trial2020

Medication Comparisons

Compare medications used to treat Age Related Macular Degeneration 11 C2677774. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy